The neuroimaging spectrum of SLC13A5 related developmental and epileptic encephalopathy

Robyn Whitney1, Elaine Choi1, Kevin C Jones1

  • 1Division of Neurology, Department of Paediatrics, McMaster University, 1200 Main Street West, Hamilton, ON, Canada.

Seizure
|January 26, 2023
PubMed

Insights

Neuroimaging abnormalities, particularly punctate white matter lesions (PWMLs), are present in about a third of SLC13A5 related developmental and epileptic encephalopathy (DEE) cases. These findings highlight the importance of neuroimaging in diagnosing this rare genetic disorder.

Area of Science:

  • Neurogenetics
  • Pediatric Neurology
  • Medical Imaging

Background:

  • SLC13A5 related developmental and epileptic encephalopathy (DEE) is a severe autosomal recessive disorder.
  • Key features include neonatal seizures, fever sensitivity, developmental delay, and tooth anomalies.
  • The neuroimaging spectrum of SLC13A5-DEE is not well-characterized.

Observation:

  • A case of SLC13A5-DEE presented with widespread punctate white matter lesions (PWMLs) on early MRI, mimicking metabolic or infectious etiologies.
  • Follow-up MRI showed atrophy and white matter necrosis.
  • A literature review identified 105 cases of SLC13A5-DEE.

Findings:

  • Neuroimaging abnormalities were observed in 34% of reviewed SLC13A5-DEE cases.
  • White matter abnormalities, including PWMLs (38%), were the most frequent findings.
  • Initial MRIs were normal in 66% of cases, underscoring variability.

Implications:

  • Neuroimaging plays a crucial role in diagnosing SLC13A5-DEE, with white matter lesions being a key indicator.
  • Understanding the susceptibility to these lesions and their long-term impact on neurodevelopment requires further investigation.
  • This study expands the known neuroimaging findings in SLC13A5-DEE, aiding in diagnosis and future research.
Abstract